Skip to main content

Maria Carme Dinarès Fernández

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Maria Carme Dinarès Fernández

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

A randomized controlled study to assess the efficacy of topical Sinecathechins used as adjuvant therapy to topical ablative trichloroacetic acid in the Treatment of anal Highgrade squamous intraepithelial lesion: The SINECHSIL study.

IP: Joaquin Burgos Cibrian
Collaborators: Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Maria Carme Dinarès Fernández, Bibiana Planas Ribas, Vicente Descalzo Jorro, Marta Sanchiz Cruz, David Campany Herrero, Stefania Landolfi
Funding agency: Fundació La Marató de TV3
Funding: 191645
Reference: 202404-10
Duration: 31/03/2025 - 30/03/2028

Investigación del mecanismo de acción de la Talidomida en el Lupus Discoide para el desarrollo de nuevas terapias

IP: Josefina Cortes Hernandez
Collaborators: Maria Carme Dinarès Fernández, Jordi Mollet Sánchez, Cristina Solé Marce
Funding agency: Instituto de Salud Carlos III
Funding: 104665
Reference: PI15/02145
Duration: 01/01/2016 - 31/12/2019

Neurodegeneración en la patogénesis de la retinopatía diabética incipiente. Estudio de los mecanismos impllicados a través de un abordaje integrado de biología de sistemas

IP: Rafael Simó Canonge
Collaborators: Maria Carme Dinarès Fernández, Dulce María Moncho Rodríguez, Ana Boixadera Espax, Marta Rosal Fontana, Miguel Angel Zapata Victori
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 181500
Reference: SAF2009-07408
Duration: 01/01/2010 - 31/12/2012

Ministerio de Ciencia

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Pau  Rello Sabaté

Pau Rello Sabaté

Predoctoral researcher
Cardiovascular Diseases
Read more
Mª Teresa Tórtola Fernández

Mª Teresa Tórtola Fernández

Senior researcher
Microbiology
Read more
Montse Bosch Ferrer

Montse Bosch Ferrer

Senior researcher
Clinical Pharmacology
Read more
Jordi Gómez i Prat

Jordi Gómez i Prat

Senior researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.